AcelRx Pharmaceuticals Inc (ACRX) stock has fallen -23.64% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ACRX stock a score of 72 out of a possible 100.
That rank is influenced by a long-term technical score of 94. ACRX's rank also includes a fundamental score of 87. In addition to the average rating from Wall Street analysts, ACRX stock has a mean target price of 6. This means analysts expect the stock to climb 257.14% over the next 12 months. The short-term technical score for ACRX is 35.
What's Happening with ACRX Stock Today
AcelRx Pharmaceuticals Inc (ACRX) stock has fallen -9.19% while the S&P 500 has fallen -0.3% as of 2:15 PM on Thursday, Oct 15. ACRX has fallen -$0.17 from the previous closing price of $1.85 on volume of 1,534,054 shares. Over the past year the S&P 500 is higher by 16.34% while ACRX has fallen -23.64%. ACRX lost -$0.62 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on AcelRx Pharmaceuticals Inc (ACRX) Stock.